About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Epilepsy Clinical Trials | 925 Studies Recruiting

Clinical TrialsEpilepsy

Epilepsy Clinical Trials

Browse 925 clinical trials for epilepsy. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 841-860 of 925 trials

RecruitingA Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet SyndromeENDEAVOR is a Phase 1/2, 2-part, multicenter study to evaluate the safety and efficacy of ETX101 in participants with SCN1A-positive Dravet syndrome aged ≥6 to \<36 months (Part…NCT05419492·San Francisco, California and 13 others CompletedEfficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial SeizuresThis was a phase III 4-part study in multiple centres.NCT00957684·São Mamede do Coronado

Related Searches

Data from ClinicalTrials.govTerms

Enrolling by invitationSLC13A5 Deficiency Natural History Study - Remote OnlySLC13A5 deficiency (Citrate Transporter Disorder, EIEE 25) is a rare genetic disorder with neurodevelopmental delays and seizure onset in the first few days of life.NCT04681781·Palo Alto, California

CompletedA Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.The purpose of this study is to demonstrate that RWJ-333369 is safe and effective as add-on treatment of partial onset seizures.NCT00433667

Not yet recruitingHuman Cognition During Surgery: Stimulation-based and Cholinergic ModulationThis is a research study to determine how COBENFY KarXT (FDA approved), a drug which has been approved for treatment of certain disorders, affects brain activity and cognitive…NCT07721272·Dallas, Texas

CompletedDexmedetomidine and Propofol for Pediatric MRI SedationThe purpose of this study is to compare the results of combining two anesthetic medications (dexmedetomidine and propofol) in low doses with a standard dose of a single drug that…NCT03513757·Milwaukee, Wisconsin

CompletedPilot Study of Melatonin and EpilepsyThe prevalence of epilepsy is 1% in the USA. About 30% of epilepsy patients eventually become refractory to medical treatment.NCT00965575·Cincinnati, Ohio

RecruitingGenotype, Phenotype, and Disease Progression of Developmental Epileptic Encephalopathy With Onset Before 2 Years of AgeAccording to estimates by the World Health Organization in 2019, more than 50 million people around the world have epilepsy.NCT06278428·Ho Chi Minh City and 1 other

Approved for marketingCenobamate Expanded Access Program (EAP)This Cenobamate Expanded Access Program (EAP) is designed to continue providing treatment with Cenobamate (YKP3089) to patients with partial-onset epilepsy that were enrolled in…NCT04513860

CompletedCortical Excitability and Treatment Response in People with EpilepsyEpilepsy is a medical condition marked by the occurrence of unpredictable, recurrent seizures.NCT05551403·Heemstede, North Holland and 1 other

CompletedValidation of Criteria for Identification of Epileptiform Discharges in EEG Recordings of Patients With EpilepsyElectroencephalography (EEG) records electric activity of the brain using electrodes placed on the scalp.NCT03533374

CompletedSafety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial SeizuresSubjects enrolled in the SP615, SP756, or SP774 open-label extension (OLE) trials receiving oral SPM 927 for at least 8 weeks and a stable dose of up to 3 antiepileptic…NCT00151879·RTP, North Carolina

CompletedCreation, Implementation, and Analysis of a Seizure Action PlanData strongly suggests that aggressive and early treatment of status epilepticus (SE) is crucial for seizure abortion and prevention of long-term neurologic sequelae.NCT02995759·Boston, Massachusetts

UnknownDetecting PNES With Single-channel sEMGThis is a prospective, comparative, multicenter study of subjects being admitted for standard of care therapy in Epilepsy Monitoring Units in the Veteran's Affair (VA) Medical…NCT03313362·Durham, North Carolina and 2 others

CompletedSafety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset SeizuresThis is a multicenter, open label study to assess the safety and pharmacokinetics of YKP3089 as adjunctive therapy in subjects with partial onset seizures.NCT02535091·Phoenix, Arizona and 120 others

CompletedSafety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly PatientsThis is an open Label study to investigate the safety and efficacy of eslicarbazepine acetate as adjunctive therapy for partial seizures in elderly patients.NCT01422720·Innsbruck and 47 others

CompletedWhy Are Patients With Absence Seizures Absent? A Brain Imaging StudyOur study examines which different brain regions are involved in child absence seizures and how they are related to attention and cognition.NCT00393666·New Haven, Connecticut

CompletedEfficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary GeneralizationThe purpose of this study is to determine whether levetiracetam as adjunctive therapy is effective in the treatment of partial seizures, with or without secondary generalization…NCT01392768

WithdrawnA Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset SeizuresThis study will evaluate the effectiveness and safety of seletracetam when it is used in addition to other anti-epileptic medications by patients with partial onset seizures.NCT00422110

CompletedDepression and Health Outcomes in Refractory EpilepsyTo define the benefits of antidepressant treatment or cognitive behavior therapy on mood, function, and quality of life in persons with depression and refractory epilepsy.NCT00026637·St Louis, Missouri and 1 other

PreviousPage 43 of 47Next